Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioIVT Acquires Keystone Biologicals | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioIVT Acquires Keystone Biologicals

Expands its offering of disease-state biospecimens

By: Cassandra Gervolino

BioIVT has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. The acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.
 
“With the addition of Keystone Biologicals, BioIVT broadens its product offerings and better supports clients in the in vitro diagnostic (IVD) market,” said BioIVT Chief Executive Officer Jeffrey Gatz. “This acquisition furthers our mission of becoming the partner of choice for both biopharmaceutical and diagnostic clients.”
 
“In BioIVT, we have found a like-minded partner whose desire to provide the highest quality research samples and customized products and services to satisfy client needs equals our own,” said Keystone Biologicals President Darren Lowenthal. “We are delighted to be joining BioIVT and look forward to working together for the benefit of all our clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics